Skip to main navigation
Skip to search
Skip to main content
The Hebrew University of Jerusalem Home
Approve / Request updates on publications
Link opens in a new tab
Search content at The Hebrew University of Jerusalem
Home
Profiles
Research units
Research output
Prizes
Cysteine proteases in atherosclerosis
Tommy Weiss-Sadan
, Israel Gotsman
,
Galia Blum
*
*
Corresponding author for this work
School of Pharmacy
Research output
:
Contribution to journal
›
Review article
›
peer-review
46
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Cysteine proteases in atherosclerosis'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Cathepsin
100%
Cysteine Protease
100%
Vascular Lesions
100%
Apoptosis
50%
Older Adults
50%
Inflammation
50%
Novel Therapeutics
50%
Lumen
50%
Human Tissue
50%
Lipids
50%
Lipid Metabolism
50%
Inflammatory Process
50%
Surrogate Marker
50%
Myocardial Infarction
50%
Thrombotic Events
50%
Protease
50%
Cardiovascular Disease
50%
Cardiovascular Events
50%
Molecular Imaging
50%
Inflammatory Cells
50%
Cysteine Cathepsins
50%
Atherogenesis
50%
Arterial Remodeling
50%
Arterial Wall
50%
Vascular Endothelium
50%
Preclinical Animal Models
50%
Vascular Injury
50%
Point-of-care Diagnostics
50%
Tissue Factor
50%
Instigation
50%
Cellular Process
50%
Remodeling Process
50%
Pharmacology, Toxicology and Pharmaceutical Science
Atherosclerosis
100%
Cysteine Proteinase
100%
Cathepsin
75%
Lipid
50%
Vascular Lesion
50%
Inflammation
25%
Heart Infarction
25%
Proteinase
25%
Cerebrovascular Accident
25%
Cysteine
25%
Cellular Processes
25%
Thromboplastin
25%
Atherogenesis
25%
Blood Vessel Injury
25%
Disease Marker
25%
Cardiovascular Disease
25%
Immunology and Microbiology
Atherosclerosis
100%
Cysteine
100%
Cardiovascular System
50%
Human Tissue
25%
Lipid Metabolism
25%
Inflammatory Cell
25%
Lipoapoptosis
25%
Molecular Imaging
25%
Vascular Endothelium
25%
Thromboplastin
25%
Inflammation
25%
Proteinase
25%
Protease
25%
Biochemistry, Genetics and Molecular Biology
Lipoapoptosis
33%